Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose A Halperin

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|October 5, 2013
Small-Molecule targeting of translation initiation for cancer therapyBertal H Aktas, Yuan Qiao, Esra Ozdelen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 2, 2022
The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI StudyDelia Bogdanet, Miguel Angel Luque-Fernandez, Michelle Toth-Castillo, et al.
Circulation|March 10, 2010
Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in miceGongxiong Wu, Ting Chen, Aliakbar Shahsafaei, et al.
Journal of Medicinal Chemistry|April 2, 2004
3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibitionAmarnath Natarajan, Yun-Hua Fan, Han Chen, et al.
American Journal of Hematology|May 15, 2013
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetesPamela Ghosh, Rupam Sahoo, Anand Vaidya, et al.
Blood|June 1, 2010
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelWeiguo Hu, Richard Jin, Jinyan Zhang, et al.
Journal of Medicinal Chemistry|October 1, 2004
Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiationAmarnath Natarajan, Yuhong Guo, Frederick Harbinski, et al.
Journal of Medicinal Chemistry|May 16, 2014
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interactionPoornachandran Mahalingam, Khuloud Takrouri, Ting Chen, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Acta Diabetologica|October 30, 2022
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|October 5, 2013
Small-Molecule targeting of translation initiation for cancer therapyBertal H Aktas, Yuan Qiao, Esra Ozdelen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 2, 2022
The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI StudyDelia Bogdanet, Miguel Angel Luque-Fernandez, Michelle Toth-Castillo, et al.
Circulation|March 10, 2010
Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in miceGongxiong Wu, Ting Chen, Aliakbar Shahsafaei, et al.
Journal of Medicinal Chemistry|April 2, 2004
3,3-diaryl-1,3-dihydroindol-2-ones as antiproliferatives mediated by translation initiation inhibitionAmarnath Natarajan, Yun-Hua Fan, Han Chen, et al.
American Journal of Hematology|May 15, 2013
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetesPamela Ghosh, Rupam Sahoo, Anand Vaidya, et al.
Blood|June 1, 2010
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelWeiguo Hu, Richard Jin, Jinyan Zhang, et al.
Journal of Medicinal Chemistry|October 1, 2004
Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiationAmarnath Natarajan, Yuhong Guo, Frederick Harbinski, et al.
Journal of Medicinal Chemistry|May 16, 2014
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interactionPoornachandran Mahalingam, Khuloud Takrouri, Ting Chen, et al.
Journal of Clinical Medicine|July 9, 2022
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Acta Diabetologica|October 30, 2022
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
Pageof 5